Loading clinical trials...
Loading clinical trials...
Predictors of Health-Related Quality of Life in Adults With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions
Interventions
Bruton's tyrosine kinase inhibitor
B-Cell Lymphoma 2 Protein Inhibitor
Locations
1
United States
Moffitt Cancer Center
Tampa, Florida, United States
Start Date
July 17, 2025
Primary Completion Date
June 1, 2028
Completion Date
June 1, 2028
Last Updated
April 1, 2026
NCT06043011
NCT06528301
NCT03342144
NCT05168930
NCT04758975
NCT04488354
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions